Peppi Prasit
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Peroxisome Proliferator-Activated Receptors 5
- Receptor Mechanisms and Signaling 4
- Bone Metabolism and Diseases 4
- Physiology 13
- Asthma and respiratory diseases 12
- Co-authors
- Daniel S. Lorrain (18 shared papers)John H. Hutchinson (16 shared papers)Charles W. Chapman (8 shared papers)Jilly F. Evans (15 shared papers)Renata M. Oballa (5 shared papers)Gretchen Bain (14 shared papers)Lucia Correa (12 shared papers)Nicholas Stock (15 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (4 papers)Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)European Journal of Pharmacology (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Peppi Prasit
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Pharmacology 176
- Cancer Research 140
- Biochemistry 66
- Physiology 215
- Immunology and Allergy 50
Countries citing papers authored by Peppi Prasit
This map shows the geographic impact of Peppi Prasit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peppi Prasit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peppi Prasit more than expected).
Fields of papers citing papers by Peppi Prasit
This network shows the impact of papers produced by Peppi Prasit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peppi Prasit. The network helps show where Peppi Prasit may publish in the future.
Co-authors
The 25 scholars most cited alongside Peppi Prasit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 207 | |
| 2 | 2000 | 108 | |
| 3 | 2010 | 102 | |
| 4 | 2003 | 66 | |
| 5 | 2008 | 50 | |
| 6 | 2003 | 43 | |
| 7 | 2010 | 42 | |
| 8 | 2009 | 40 | |
| 9 | 2011 | 39 | |
| 10 | 2009 | 37 | |
| 11 | 2015 | 37 | |
| 12 | 2009 | 35 | |
| 13 | 2000 | 33 | |
| 14 | 2010 | 25 | |
| 15 | 2017 | 25 | |
| 16 | 2014 | 24 | |
| 17 | 2023 | 23 | |
| 18 | 2004 | 22 | |
| 19 | A new class of leukotriene biosynthesis inhibitor: the development of MK-0591. | 1993 | 21 |
| 20 | 2011 | 20 |
About Peppi Prasit
Peppi Prasit is a scholar working on Molecular Biology, Physiology, Pharmacology, Cancer Research and Organic Chemistry, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (12 papers), Inflammatory mediators and NSAID effects (10 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Protease and Inhibitor Mechanisms (5 papers), Receptor Mechanisms and Signaling (4 papers), Estrogen and related hormone effects (4 papers), Bone Metabolism and Diseases (4 papers) and Synthesis and Biological Evaluation (4 papers). The work is most often cited by research in Pharmacology (176 citations), Cancer Research (140 citations), Biochemistry (66 citations), Physiology (215 citations) and Immunology and Allergy (50 citations). Peppi Prasit has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Daniel S. Lorrain, John H. Hutchinson, Charles W. Chapman, Jilly F. Evans, Renata M. Oballa, Gretchen Bain, Lucia Correa, Nicholas Stock, Angelina M. Santini and Christopher Baccei. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Clinical Oncology, Cancer Research and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.